Safety and Efficacy of an Initial Regimen of Atazanavir + Ritonavir + the Abacavir/Lamivudine Fixed-Dose Combination Tablet for 36 weeks followed by Simplification to Atazanavir with ABC/3TC FTC or Maintenance of the Initial Regimen for an Additional 48

Detalles del proyecto

EstadoFinalizado
Fecha de inicio/Fecha fin7/1/07 → 8/31/13

Financiación

  • GlaxoSmithKline: 75.114,00 US$